The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Re-treatment of metastatic castration-resistant prostate cancer patients with radium-223 therapy in daily practice.
 
Maarten van der Doelen
Research Funding - Bayer HealthCare Pharmacuticals (Inst)
 
Joost van Riel
No Relationships to Disclose
 
Maarten Donswijk
No Relationships to Disclose
 
Christel Brouwer
No Relationships to Disclose
 
Winald Gerritsen
Consulting or Advisory Role - Bayer; coretag; MSD Oncology; Novartis; ORCA Therapeutics
Expert Testimony - Astellas Medivation
 
Ha Tan-Phan
No Relationships to Disclose
 
Willie Thimister
No Relationships to Disclose
 
Walter Noordzij
No Relationships to Disclose
 
Erik te Beek
No Relationships to Disclose
 
Laurence van Warmerdam
No Relationships to Disclose
 
Andre Bergman
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi
Research Funding - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Bayer
 
Inge van Oort
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer
Research Funding - Astellas Oncology (Inst); Bayer HealthCare Pharmacuticals (Inst); Janssen (Inst); MSD/AstraZeneca (Inst); Pfizer (Inst)
 
Dirk Wyndaele
No Relationships to Disclose